UniProt ID | HNRPD_HUMAN | |
---|---|---|
UniProt AC | Q14103 | |
Protein Name | Heterogeneous nuclear ribonucleoprotein D0 | |
Gene Name | HNRNPD | |
Organism | Homo sapiens (Human). | |
Sequence Length | 355 | |
Subcellular Localization | Nucleus. Cytoplasm. Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Component of ribonucleosomes. Cytoplasmic localization oscillates diurnally. | |
Protein Description | Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Also binds to double- and single-stranded DNA sequences in a specific manner and functions a transcription factor. Each of the RNA-binding domains specifically can bind solely to a single-stranded non-monotonous 5'-UUAG-3' sequence and also weaker to the single-stranded 5'-TTAGGG-3' telomeric DNA repeat. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats. Binding of RRM1 to DNA inhibits the formation of DNA quadruplex structure which may play a role in telomere elongation. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. May play a role in the regulation of the rhythmic expression of circadian clock core genes. Directly binds to the 3'UTR of CRY1 mRNA and induces CRY1 rhythmic translation. May also be involved in the regulation of PER2 translation.. | |
Protein Sequence | MSEEQFGGDGAAAAATAAVGGSAGEQEGAMVAATQGAAAAAGSGAGTGGGTASGGTEGGSAESEGAKIDASKNEEDEGHSNSSPRHSEAATAQREEWKMFIGGLSWDTTKKDLKDYFSKFGEVVDCTLKLDPITGRSRGFGFVLFKESESVDKVMDQKEHKLNGKVIDPKRAKAMKTKEPVKKIFVGGLSPDTPEEKIREYFGGFGEVESIELPMDNKTNKRRGFCFITFKEEEPVKKIMEKKYHNVGLSKCEIKVAMSKEQYQQQQQWGSRGGFAGRARGRGGGPSQNWNQGYSNYWNQGYGNYGYNSQGYGGYGGYDYTGYNNYYGYGDYSNQQSGYGKVSRRGGHQNSYKPY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSEEQFGGD ------CCHHHCCCH | 50.25 | 19413330 | |
2 | Phosphorylation | ------MSEEQFGGD ------CCHHHCCCH | 50.25 | 19413330 | |
16 | Phosphorylation | DGAAAAATAAVGGSA HHHHHHHHHHHCCCH | 15.49 | 27251275 | |
22 | Phosphorylation | ATAAVGGSAGEQEGA HHHHHCCCHHHHHHH | 27.46 | 21601212 | |
34 | Phosphorylation | EGAMVAATQGAAAAA HHHHEHHHCHHHHHC | 20.14 | 27251275 | |
43 | Phosphorylation | GAAAAAGSGAGTGGG HHHHHCCCCCCCCCC | 22.27 | 27251275 | |
47 | Phosphorylation | AAGSGAGTGGGTASG HCCCCCCCCCCCCCC | 31.92 | 27251275 | |
51 | Phosphorylation | GAGTGGGTASGGTEG CCCCCCCCCCCCCCC | 22.41 | 27251275 | |
56 | Phosphorylation | GGTASGGTEGGSAES CCCCCCCCCCCCCCC | 34.68 | 24505115 | |
60 | Phosphorylation | SGGTEGGSAESEGAK CCCCCCCCCCCCCCC | 39.45 | 22817901 | |
63 | Phosphorylation | TEGGSAESEGAKIDA CCCCCCCCCCCCCCC | 40.84 | 22817901 | |
71 | Phosphorylation | EGAKIDASKNEEDEG CCCCCCCCCCCCCCC | 32.06 | 29255136 | |
72 | Acetylation | GAKIDASKNEEDEGH CCCCCCCCCCCCCCC | 70.83 | 23749302 | |
72 | Ubiquitination | GAKIDASKNEEDEGH CCCCCCCCCCCCCCC | 70.83 | 21906983 | |
72 | Sumoylation | GAKIDASKNEEDEGH CCCCCCCCCCCCCCC | 70.83 | 28112733 | |
72 (in isoform 1) | Ubiquitination | - | 70.83 | 21890473 | |
72 (in isoform 3) | Ubiquitination | - | 70.83 | 21890473 | |
80 | Phosphorylation | NEEDEGHSNSSPRHS CCCCCCCCCCCHHHH | 49.62 | 29255136 | |
82 | Phosphorylation | EDEGHSNSSPRHSEA CCCCCCCCCHHHHHH | 44.74 | 29255136 | |
83 | Phosphorylation | DEGHSNSSPRHSEAA CCCCCCCCHHHHHHH | 30.15 | 29255136 | |
87 | Phosphorylation | SNSSPRHSEAATAQR CCCCHHHHHHHHHCH | 30.15 | 29255136 | |
91 | Phosphorylation | PRHSEAATAQREEWK HHHHHHHHHCHHHHH | 30.30 | 30266825 | |
91 (in isoform 2) | Ubiquitination | - | 30.30 | 21890473 | |
91 (in isoform 4) | Ubiquitination | - | 30.30 | 21890473 | |
94 | Methylation | SEAATAQREEWKMFI HHHHHHCHHHHHHHH | 41.14 | 115386471 | |
95 (in isoform 2) | Ubiquitination | - | 57.01 | 21890473 | |
95 (in isoform 4) | Ubiquitination | - | 57.01 | 21890473 | |
98 | Acetylation | TAQREEWKMFIGGLS HHCHHHHHHHHCCCC | 27.49 | 25953088 | |
99 | Sulfoxidation | AQREEWKMFIGGLSW HCHHHHHHHHCCCCC | 2.87 | 28183972 | |
100 (in isoform 2) | Ubiquitination | - | 4.10 | 21890473 | |
100 (in isoform 4) | Ubiquitination | - | 4.10 | 21890473 | |
105 | Phosphorylation | KMFIGGLSWDTTKKD HHHHCCCCCCCCHHH | 26.61 | - | |
108 | Phosphorylation | IGGLSWDTTKKDLKD HCCCCCCCCHHHHHH | 33.97 | 19664994 | |
110 | Acetylation | GLSWDTTKKDLKDYF CCCCCCCHHHHHHHH | 46.51 | 26051181 | |
110 | Ubiquitination | GLSWDTTKKDLKDYF CCCCCCCHHHHHHHH | 46.51 | 21906983 | |
110 (in isoform 3) | Ubiquitination | - | 46.51 | 21890473 | |
110 (in isoform 1) | Ubiquitination | - | 46.51 | 21890473 | |
110 (in isoform 2) | Ubiquitination | - | 46.51 | 21890473 | |
110 (in isoform 4) | Ubiquitination | - | 46.51 | 21890473 | |
111 | Acetylation | LSWDTTKKDLKDYFS CCCCCCHHHHHHHHH | 67.22 | 24469531 | |
111 | Ubiquitination | LSWDTTKKDLKDYFS CCCCCCHHHHHHHHH | 67.22 | - | |
111 (in isoform 3) | Ubiquitination | - | 67.22 | - | |
111 | Malonylation | LSWDTTKKDLKDYFS CCCCCCHHHHHHHHH | 67.22 | 26320211 | |
114 | Acetylation | DTTKKDLKDYFSKFG CCCHHHHHHHHHHHC | 61.59 | 25825284 | |
114 | Ubiquitination | DTTKKDLKDYFSKFG CCCHHHHHHHHHHHC | 61.59 | 21890473 | |
114 (in isoform 3) | Ubiquitination | - | 61.59 | 21890473 | |
114 | Succinylation | DTTKKDLKDYFSKFG CCCHHHHHHHHHHHC | 61.59 | 23954790 | |
114 (in isoform 1) | Ubiquitination | - | 61.59 | 21890473 | |
116 | Phosphorylation | TKKDLKDYFSKFGEV CHHHHHHHHHHHCCE | 14.25 | 28152594 | |
118 | Phosphorylation | KDLKDYFSKFGEVVD HHHHHHHHHHCCEEE | 22.35 | 28152594 | |
119 | Acetylation | DLKDYFSKFGEVVDC HHHHHHHHHCCEEEE | 47.71 | 25825284 | |
119 | Methylation | DLKDYFSKFGEVVDC HHHHHHHHHCCEEEE | 47.71 | 23161681 | |
119 | Ubiquitination | DLKDYFSKFGEVVDC HHHHHHHHHCCEEEE | 47.71 | 21890473 | |
119 (in isoform 3) | Ubiquitination | - | 47.71 | 21890473 | |
119 (in isoform 1) | Ubiquitination | - | 47.71 | 21890473 | |
126 | S-nitrosocysteine | KFGEVVDCTLKLDPI HHCCEEEEEEEECCC | 3.03 | - | |
126 | Glutathionylation | KFGEVVDCTLKLDPI HHCCEEEEEEEECCC | 3.03 | 22555962 | |
126 | S-nitrosylation | KFGEVVDCTLKLDPI HHCCEEEEEEEECCC | 3.03 | 19483679 | |
127 | Phosphorylation | FGEVVDCTLKLDPIT HCCEEEEEEEECCCC | 23.59 | 19664994 | |
129 | Acetylation | EVVDCTLKLDPITGR CEEEEEEEECCCCCC | 32.46 | 23749302 | |
129 | Ubiquitination | EVVDCTLKLDPITGR CEEEEEEEECCCCCC | 32.46 | 22053931 | |
129 (in isoform 3) | Ubiquitination | - | 32.46 | 21890473 | |
129 | Methylation | EVVDCTLKLDPITGR CEEEEEEEECCCCCC | 32.46 | 23583077 | |
129 | Sumoylation | EVVDCTLKLDPITGR CEEEEEEEECCCCCC | 32.46 | 28112733 | |
129 (in isoform 1) | Ubiquitination | - | 32.46 | 21890473 | |
134 | Phosphorylation | TLKLDPITGRSRGFG EEEECCCCCCCCCEE | 31.75 | 23403867 | |
137 | Phosphorylation | LDPITGRSRGFGFVL ECCCCCCCCCEEEEE | 37.79 | 24719451 | |
138 | Methylation | DPITGRSRGFGFVLF CCCCCCCCCEEEEEE | 43.00 | - | |
146 | Acetylation | GFGFVLFKESESVDK CEEEEEEECCCCHHH | 57.05 | 19608861 | |
153 | Acetylation | KESESVDKVMDQKEH ECCCCHHHHHHHHHH | 36.99 | 23749302 | |
153 | Ubiquitination | KESESVDKVMDQKEH ECCCCHHHHHHHHHH | 36.99 | - | |
153 (in isoform 3) | Ubiquitination | - | 36.99 | - | |
155 | Sulfoxidation | SESVDKVMDQKEHKL CCCHHHHHHHHHHHH | 5.79 | 21406390 | |
158 | Acetylation | VDKVMDQKEHKLNGK HHHHHHHHHHHHCCE | 58.48 | 25953088 | |
161 (in isoform 3) | Ubiquitination | - | 44.75 | - | |
164 (in isoform 2) | Ubiquitination | - | 35.72 | 21890473 | |
164 (in isoform 4) | Ubiquitination | - | 35.72 | 21890473 | |
165 | Acetylation | KEHKLNGKVIDPKRA HHHHHCCEECCHHHH | 34.64 | 19608861 | |
165 | Ubiquitination | KEHKLNGKVIDPKRA HHHHHCCEECCHHHH | 34.64 | 19608861 | |
165 (in isoform 3) | Ubiquitination | - | 34.64 | - | |
170 | Ubiquitination | NGKVIDPKRAKAMKT CCEECCHHHHHHCCC | 62.33 | - | |
178 (in isoform 2) | Ubiquitination | - | 55.28 | 21890473 | |
178 (in isoform 4) | Ubiquitination | - | 55.28 | 21890473 | |
183 | Ubiquitination | KTKEPVKKIFVGGLS CCCCCCCEEECCCCC | 41.43 | 21890473 | |
183 | Malonylation | KTKEPVKKIFVGGLS CCCCCCCEEECCCCC | 41.43 | 26320211 | |
183 | Acetylation | KTKEPVKKIFVGGLS CCCCCCCEEECCCCC | 41.43 | 26051181 | |
183 (in isoform 1) | Ubiquitination | - | 41.43 | 21890473 | |
183 (in isoform 3) | Ubiquitination | - | 41.43 | 21890473 | |
190 | Phosphorylation | KIFVGGLSPDTPEEK EEECCCCCCCCHHHH | 24.81 | 19664994 | |
193 | Phosphorylation | VGGLSPDTPEEKIRE CCCCCCCCHHHHHHH | 35.66 | 29255136 | |
197 | Acetylation | SPDTPEEKIREYFGG CCCCHHHHHHHHHCC | 45.46 | 23954790 | |
197 | Ubiquitination | SPDTPEEKIREYFGG CCCCHHHHHHHHHCC | 45.46 | 21890473 | |
197 | Sumoylation | SPDTPEEKIREYFGG CCCCHHHHHHHHHCC | 45.46 | 28112733 | |
197 (in isoform 3) | Ubiquitination | - | 45.46 | 21890473 | |
197 | Malonylation | SPDTPEEKIREYFGG CCCCHHHHHHHHHCC | 45.46 | 26320211 | |
197 (in isoform 1) | Ubiquitination | - | 45.46 | 21890473 | |
199 (in isoform 2) | Ubiquitination | - | 43.56 | 21890473 | |
199 (in isoform 4) | Ubiquitination | - | 43.56 | 21890473 | |
201 | Phosphorylation | PEEKIREYFGGFGEV HHHHHHHHHCCCCCE | 9.55 | 27642862 | |
210 | Phosphorylation | GGFGEVESIELPMDN CCCCCEEEEEECCCC | 26.91 | 27732954 | |
215 | Sulfoxidation | VESIELPMDNKTNKR EEEEEECCCCCCCCC | 16.14 | 30846556 | |
218 | Methylation | IELPMDNKTNKRRGF EEECCCCCCCCCCCE | 49.57 | 66728815 | |
218 | Acetylation | IELPMDNKTNKRRGF EEECCCCCCCCCCCE | 49.57 | 25953088 | |
218 | Ubiquitination | IELPMDNKTNKRRGF EEECCCCCCCCCCCE | 49.57 | 21890473 | |
218 (in isoform 3) | Ubiquitination | - | 49.57 | 21890473 | |
218 (in isoform 1) | Ubiquitination | - | 49.57 | 21890473 | |
224 (in isoform 2) | Ubiquitination | - | 27.92 | - | |
226 | S-nitrosocysteine | TNKRRGFCFITFKEE CCCCCCEEEEEECCC | 2.41 | - | |
226 | Glutathionylation | TNKRRGFCFITFKEE CCCCCCEEEEEECCC | 2.41 | 22555962 | |
226 | S-nitrosylation | TNKRRGFCFITFKEE CCCCCCEEEEEECCC | 2.41 | 19483679 | |
231 | Acetylation | GFCFITFKEEEPVKK CEEEEEECCCCHHHH | 56.41 | 25825284 | |
231 | Ubiquitination | GFCFITFKEEEPVKK CEEEEEECCCCHHHH | 56.41 | - | |
232 | Acetylation | FCFITFKEEEPVKKI EEEEEECCCCHHHHH | 64.50 | 19608861 | |
232 | Ubiquitination | FCFITFKEEEPVKKI EEEEEECCCCHHHHH | 64.50 | 19608861 | |
237 | Malonylation | FKEEEPVKKIMEKKY ECCCCHHHHHHHHHH | 47.50 | 26320211 | |
237 | Acetylation | FKEEEPVKKIMEKKY ECCCCHHHHHHHHHH | 47.50 | 25953088 | |
238 | Acetylation | KEEEPVKKIMEKKYH CCCCHHHHHHHHHHH | 47.74 | 30583115 | |
241 (in isoform 2) | Ubiquitination | - | 50.28 | - | |
243 | Acetylation | VKKIMEKKYHNVGLS HHHHHHHHHHCCCCC | 38.13 | 23749302 | |
243 | Ubiquitination | VKKIMEKKYHNVGLS HHHHHHHHHHCCCCC | 38.13 | - | |
244 | Phosphorylation | KKIMEKKYHNVGLSK HHHHHHHHHCCCCCH | 15.08 | 28152594 | |
250 | Phosphorylation | KYHNVGLSKCEIKVA HHHCCCCCHHEEEEE | 29.36 | 24961811 | |
251 | Acetylation | YHNVGLSKCEIKVAM HHCCCCCHHEEEEEE | 40.71 | 19608861 | |
251 | Ubiquitination | YHNVGLSKCEIKVAM HHCCCCCHHEEEEEE | 40.71 | 19608861 | |
251 (in isoform 3) | Ubiquitination | - | 40.71 | - | |
251 | Malonylation | YHNVGLSKCEIKVAM HHCCCCCHHEEEEEE | 40.71 | 26320211 | |
255 | Ubiquitination | GLSKCEIKVAMSKEQ CCCHHEEEEEECHHH | 11.14 | - | |
255 | Acetylation | GLSKCEIKVAMSKEQ CCCHHEEEEEECHHH | 11.14 | 25953088 | |
260 | Methylation | EIKVAMSKEQYQQQQ EEEEEECHHHHHHHH | 35.43 | 115479067 | |
260 | Ubiquitination | EIKVAMSKEQYQQQQ EEEEEECHHHHHHHH | 35.43 | - | |
260 (in isoform 3) | Ubiquitination | - | 35.43 | - | |
263 | Phosphorylation | VAMSKEQYQQQQQWG EEECHHHHHHHHHHH | 14.91 | 23917254 | |
263 (in isoform 4) | Methylation | - | 14.91 | 24129315 | |
269 (in isoform 4) | Phosphorylation | - | 11.46 | 26434776 | |
271 | Phosphorylation | QQQQQWGSRGGFAGR HHHHHHHCCCCHHHC | 25.45 | 23186163 | |
271 (in isoform 4) | Phosphorylation | - | 25.45 | 26434776 | |
272 | Dimethylation | QQQQWGSRGGFAGRA HHHHHHCCCCHHHCC | 45.36 | - | |
272 | Methylation | QQQQWGSRGGFAGRA HHHHHHCCCCHHHCC | 45.36 | 24129315 | |
273 (in isoform 4) | Acetylation | - | 36.95 | 19608861 | |
273 | Acetylation | QQQWGSRGGFAGRAR HHHHHCCCCHHHCCC | 36.95 | 19608861 | |
275 (in isoform 4) | Phosphorylation | - | 7.89 | 26434776 | |
277 | Methylation | GSRGGFAGRARGRGG HCCCCHHHCCCCCCC | 22.86 | 15782174 | |
278 | Dimethylation | SRGGFAGRARGRGGG CCCCHHHCCCCCCCC | 20.06 | - | |
278 | Methylation | SRGGFAGRARGRGGG CCCCHHHCCCCCCCC | 20.06 | 24129315 | |
280 | Dimethylation | GGFAGRARGRGGGPS CCHHHCCCCCCCCCC | 33.70 | - | |
280 | Methylation | GGFAGRARGRGGGPS CCHHHCCCCCCCCCC | 33.70 | 24129315 | |
282 | Dimethylation | FAGRARGRGGGPSQN HHHCCCCCCCCCCCC | 34.72 | - | |
282 | Methylation | FAGRARGRGGGPSQN HHHCCCCCCCCCCCC | 34.72 | 18583695 | |
282 (in isoform 3) | Methylation | - | 34.72 | 24129315 | |
285 | Acetylation | RARGRGGGPSQNWNQ CCCCCCCCCCCCCCC | 22.85 | 19608861 | |
288 (in isoform 3) | Phosphorylation | - | 63.19 | 26434776 | |
290 (in isoform 3) | Phosphorylation | - | 7.29 | 26434776 | |
292 (in isoform 3) | Ubiquitination | - | 43.76 | - | |
292 (in isoform 3) | Acetylation | - | 43.76 | 19608861 | |
294 (in isoform 3) | Phosphorylation | - | 5.51 | 26434776 | |
341 | Acetylation | NQQSGYGKVSRRGGH CCCCCCCCCCCCCCC | 28.67 | 26051181 | |
343 | Phosphorylation | QSGYGKVSRRGGHQN CCCCCCCCCCCCCCC | 21.53 | - | |
345 | Asymmetric dimethylarginine | GYGKVSRRGGHQNSY CCCCCCCCCCCCCCC | 48.19 | - | |
345 | Methylation | GYGKVSRRGGHQNSY CCCCCCCCCCCCCCC | 48.19 | 24129315 | |
351 | Phosphorylation | RRGGHQNSYKPY--- CCCCCCCCCCCC--- | 28.15 | 26055452 | |
353 | Methylation | GGHQNSYKPY----- CCCCCCCCCC----- | 37.35 | 19608861 | |
353 | Acetylation | GGHQNSYKPY----- CCCCCCCCCC----- | 37.35 | 19608861 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
83 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
87 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
87 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
87 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
193 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | VHL | P40337 | PMID:22086907 |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:24658274 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
345 | R | Methylation |
| 15782174 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HNRPD_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-165; LYS-251; LYS-341 ANDLYS-353, AND MASS SPECTROMETRY. | |
Methylation | |
Reference | PubMed |
"Identifying and quantifying in vivo methylation sites by heavy methylSILAC."; Ong S.E., Mittler G., Mann M.; Nat. Methods 1:119-126(2004). Cited for: METHYLATION [LARGE SCALE ANALYSIS] AT ARG-345, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-190 AND THR-193,AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-83, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190 AND THR-193, ANDMASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-83; SER-190 ANDTHR-193, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83 AND THR-193, AND MASSSPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80; SER-82; SER-83;SER-87 AND THR-91, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-190 AND THR-193, ANDMASS SPECTROMETRY. |